Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dietary fibre for the primary prevention of cardiovascular disease.
Hartley L, May MD, Loveman E, Colquitt JL, Rees K. Hartley L, et al. Among authors: colquitt jl. Cochrane Database Syst Rev. 2016 Jan 7;2016(1):CD011472. doi: 10.1002/14651858.CD011472.pub2. Cochrane Database Syst Rev. 2016. PMID: 26758499 Free PMC article. Review.
Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.
Al-Khudairy L, Loveman E, Colquitt JL, Mead E, Johnson RE, Fraser H, Olajide J, Murphy M, Velho RM, O'Malley C, Azevedo LB, Ells LJ, Metzendorf MI, Rees K. Al-Khudairy L, et al. Among authors: colquitt jl. Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012691. doi: 10.1002/14651858.CD012691. Cochrane Database Syst Rev. 2017. PMID: 28639320 Free PMC article. Review.
Whole grain cereals for the primary or secondary prevention of cardiovascular disease.
Kelly SA, Hartley L, Loveman E, Colquitt JL, Jones HM, Al-Khudairy L, Clar C, Germanò R, Lunn HR, Frost G, Rees K. Kelly SA, et al. Among authors: colquitt jl. Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD005051. doi: 10.1002/14651858.CD005051.pub3. Cochrane Database Syst Rev. 2017. PMID: 28836672 Free PMC article. Review.
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.
Johnston R, Uthman O, Cummins E, Clar C, Royle P, Colquitt J, Tan BK, Clegg A, Shantikumar S, Court R, O'Hare JP, McGrane D, Holt T, Waugh N. Johnston R, et al. Health Technol Assess. 2018 Feb;21(2):219-220. doi: 10.3310/hta21020-c201802. Health Technol Assess. 2018. PMID: 29508697 Free article. No abstract available.
67 results